The cyclin D3-CDK4-p27kip1 holoenzyme in thyroid epithelial cells: activation by TSH, inhibition by TGFβ, and phosphorylations of its subunits demonstrated by two-dimensional gel electrophoresis-Reference-Cited by-同舟云学术

The cyclin D3-CDK4-p27kip1 holoenzyme in thyroid epithelial cells: activation by TSH, inhibition by TGFβ, and phosphorylations of its subunits demonstrated by two-dimensional gel electrophoresis

Published:2003-11 Issue:1 Volume:291 Page:135-149
ISSN:0014-4827
Container-title:Experimental Cell Research
language:en
Short-container-title:Experimental Cell Research

Author:

Coulonval Katia,Bockstaele Laurence,Paternot Sabine,Dumont Jacques E,Roger Pierre P

Publisher

Elsevier BV

Subject

Cell Biology

Reference76 articles.

1. D-type cyclins, Trends;Sherr;Biochem. Sci.,1995

2. The retinoblastoma protein pathway and the restriction point;Bartek;Curr. Opin. Cell Biol.,1996

3. Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes;Lundberg;Mol. Cell Biol.,1998

4. Regulation of the retinoblastoma protein-related p107 by G1 cyclin complexes;Beijersbergen;Genes Dev.,1995

5. Differential phosphorylation of the retinoblastoma protein by G1/S cyclin-dependent kinases;Zarkowska;J. Biol. Chem.,1997

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Defining the In Vivo Role of mTORC1 in Thyrocytes by Studying the TSC2 Conditional Knockout Mouse Model;Thyroid®;2024-08-01

2. Defining thein vivorole of mTORC1 in thyrocytes by studying the TSC2 conditional knockout mouse model;2023-11-04

3. CDK4 phosphorylation status and rational use for combining CDK4/6 and BRAF/MEK inhibition in advanced thyroid carcinomas;Frontiers in Endocrinology;2023-10-26

4. CDK4 phosphorylation status and rational use for combining CDK4/6 and BRAF/MEK inhibition in advanced thyroid carcinomas;2023-06-07

5. CDK4/6 Inhibitors in Pancreatobiliary Cancers: Opportunities and Challenges;Cancers;2023-02-03